[Myeloma therapy (3) Trends in development of new drugs]

Rinsho Ketsueki. 2013 Aug;54(8):715-8.
[Article in Japanese]
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use
  • Multiple Myeloma / drug therapy*
  • Proteasome Inhibitors / therapeutic use

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Proteasome Inhibitors